Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Imaging of Common Rheumatic Joint Diseases Affecting the Upper Limbs

    Research output: Contribution to journalReviewResearchpeer-review

  2. Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.
Original languageEnglish
JournalExcerpta Medica. Section 31: Arthritis and Rheumatism
Issue number5
Pages (from-to)1213-23
Number of pages11
Publication statusPublished - May 2013

ID: 38610876